期刊文献+

β-葡萄糖苷酶激活苦杏仁苷诱导膀胱癌EJ细胞凋亡的实验研究 被引量:11

Bladder cancer cells apoptosis induced by amygdalin following specific activation by β-glucosidase
暂未订购
导出
摘要 目的观察β-葡萄糖苷酶激活苦杏仁苷对膀胱癌EJ细胞生长及凋亡的影响,探讨β-葡萄糖苷酶/苦杏仁苷酶解前药系统用于膀胱癌治疗的应用前景。方法用不同浓度的苦杏仁苷与β-葡萄糖苷酶共同作用于膀胱癌EJ细胞株,用MTT法检测细胞的增殖活性,倒置显微镜和透射电镜观察细胞形态学改变,流式细胞仪检测细胞凋亡率与凋亡周期。结果与单纯用苦杏仁苷作用相比,加入β-葡萄糖苷酶后膀胱癌EJ细胞的增殖明显受限,增值抑制率可以达到前者的8.19倍;倒置显微镜和透射电镜观察到肿瘤细胞呈现凋亡的表现,流式细胞仪检测肿瘤细胞凋亡率增加、多数肿瘤细胞阻滞于S期,这些改变随着苦杏仁苷浓度的增加而明显增强。结论β-葡萄糖苷酶激活苦杏仁苷后能够明显抑制EJ细胞的增长,其作用机制可能与将肿瘤细胞阻滞于S期而诱导其凋亡有关;β-葡萄糖苷酶/苦杏仁苷酶解前药系统可能成为治疗膀胱癌的有效策略。 Objective To explore the effects of amygdalin activated by β-glucosidase on the growth and apoptosis of bladder cancer EJ cells,and to discuss β-glucosidase/amygdalin enzyme prodrug system as a potential therapy for bladder cancer.Methods EJ cells were divided into two groups: the amygdalin group,and the β-glucosidase/amygdalin group.After the treatment,the cell growth curve was determined by methyl thiazolyl tetrazolium(MTT).The inverted microscope and transmission electron microscope were used to detect the change of morphology of EJ cells.The apoptosis and cycle of EJ cells were tested by flow cytometry.Results The cell proliferation capability in the β-glucosidase/amygdalin group was significantly inhibited,and the inhibition rate was up to 8.19 times of that in the amygdalin group.The inverted microscope and transmission electron microscope showed a notable apoptosis in the β-glucosidase/amygdalin group.The flow cytometry showed that the β-glucosidase/amygdalin group had a higher apoptosis rate,and more S phase cells.With amygdalin concentration increased,these changes were more obvious.Conclusion Amygdalin activated by β-glucosidase can decrease the proliferation and promote the apoptosis capability of EJ cells,which may explain the reason why more cells were blocked in S phase.β-glucosidase/amygdalin enzyme prodrug system may become a potential therapy for bladder cancer.
出处 《现代泌尿外科杂志》 CAS 2013年第2期113-116,共4页 Journal of Modern Urology
基金 国家自然科学基金(No.81160314 No.30700836)
关键词 苦杏仁苷 Β-葡萄糖苷酶 膀胱肿瘤 凋亡 amygdalin β-glucosidase bladder cancer apoptosis
  • 相关文献

参考文献8

  • 1MILAZZO S, ERNST E, BOEHM K, et al. Laetrile treatment for cancer[J]. Coehrane Database Syst Rev, 2011,11 CD005476.
  • 2SIEGEL R,NAISHADHAM D,JEMAIA. Cancer statistics[J]. CA Cancer J Clin,2012,62(1) :10 29.
  • 3KAUFMAN DS, SHIPLY WU, FELDMAN AS. Bladder cancer [J]- Lancet,2009, 373(9686) :239 249.
  • 4GUHASARKAR S, BANERJEE R. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies [J]. J Control Release. 2010,148(2) : 147-159.
  • 5SCHELLMANN N, DECKERT PM, BACHRAN D, et al. Targeted enzyme prodrug therapies E J. Mini Rev in Medic Chem, 2010,10(10) :887-904.
  • 6许宁侠.苦杏仁苷的研究进展[J].内蒙古中医药,2012,31(9):66-67. 被引量:16
  • 7SYRIGOS KN, ROWLINSON-BUSZA G, EPENETOS AA. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated mono clonalantibody[J]. Int J Cancer. 1998,78(6) :712-719.
  • 8连彦军,陈道达,许天文,郑勇斌,黄韬,柯茂林.抗-CEA单抗-β-葡萄糖苷酶偶联物特异性激活苦杏仁苷对LoVo细胞的细胞毒作用研究[J].中国普外基础与临床杂志,2005,12(2):138-141. 被引量:12

二级参考文献21

  • 1朱友平,苏中武,李承祜.苦杏仁甙的镇痛作用和无身体依赖性[J].中国中药杂志,1994,19(2):105-107. 被引量:29
  • 2杨晓宇,陈锦屏.杏仁的营养保健功能及其在食品工业中的应用[J].食品科学,2005,26(9):629-631. 被引量:61
  • 3杨小平,张春梅,冯霞,杨俊何.苦杏仁苷口服制剂临床疗效初探[J].中药材,2006,29(6):636-637. 被引量:16
  • 4刘青云.中药药理学[M].北京:人民卫生出版社,1992.12.
  • 5庞志功 汪宝琪.用化学发光法测定苦杏仁试的含量.西北药学杂志,1988,34:2-2.
  • 6Payne G. Progress in immunoconjugate cancer therapeutics [J]. Cancer Cell, 2003; 3(3):207.
  • 7Jung M. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy [J]. Mini Rev Med Chem, 2001; 1(4):399.
  • 8Papot S, Tranoy I, Tillequin F,et al. Design of selectively activated anticancer prodrugs: elimination and cyclization strategies [J]. Curr Med Chem Anti-Canc Agents, 2002; 2(2):155.
  • 9HariKrishna D, Rao AR, Krishna DR. Selective activation of anthracycline prodrugs for use in conjunction with ADEPT [J]. Drug News Perspect, 2003; 16(5):309.
  • 10Bouvier E, Thirot S, Schmidt F,et al. A new paclitaxel prodrug for use in ADEPT strategy [J]. Org Biomol Chem, 2003; 1(19):3343.

共引文献26

同被引文献279

引证文献11

二级引证文献346

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部